Tenderwize
Wróć do wyszukiwania

Supply of pharmaceutical products for compassionate and early access use

31 CHU·Toulouse, France·EUR 450M·Deadline Apr 02, 2034 · 2777 days left·Restricted·Supplies·DPS
Zarejestruj się, aby zapisaćOpen documents
High valueStructured notice only
Oryginalny tytuł ogłoszenia

France – Pharmaceutical products – FOURNITURE DE MEDICAMENTS en accès compassionnels et en accès précoces (ex-ATU)

65/100

Ocena szansy

Needs reviewHigh complexity
SuppliesDPSOpen
Skąd ta ocena?

Szansa

65 / 100

Złożoność

70 / 100

Czynniki ryzyka

Since the DPS has been running since 2017, many operators are already admitted, leading to intense competition in mini-...

DPS does not guarantee any contracts; each specific contract is awarded via separate mini-competitions. Estimated value...

Restricted procedure — pre-qualification required

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • EUR 450M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration until Apr 2034
  • Supply of pharmaceutical products under compassionate access and early access (ex-ATU) authorizations.
  • DPS covers all product categories (no breakdown).
Pokaż pełne podsumowanie

This notice is a corrigendum extending a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products for compassionate and early access use (ex-ATU) in France. The DPS, managed by CHU de Toulouse on behalf of the UniHA group, was originally established in 2017 and is now extended by 120 months (until April 2034). Estimated annual value is €450 million (€1.8 billion total over 10 years). The DPS is open to new operators, but existing participants are automatically retained. No procurement documents were analyzed, and key details (eligibility, award criteria) are missing from the provided data.

Ryzyka

Since the DPS has been running since 2017, many operators are already admitted, leading to intense competition in mini-...

DPS does not guarantee any contracts; each specific contract is awarded via separate mini-competitions. Estimated value...

Restricted procedure — pre-qualification required

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Operators already admitted in the original DPS are automatically retained and do not need to reapply.

Administrative

  • New operators must submit an application via the e-procurement platform (www.marches-publics.gouv.fr).
  • All submissions must be made electronically.

Wymagania mogą być niepełne.

Zamawiający

Nazwa

31 CHU

Lokalizacja

Toulouse, FRA

Profil zamawiającego

Otwórz profil

Identyfikator

26310012500016

Działalność

Health

Części (1)

LOT-0001

Supply of pharmaceutical products for compassionate and early access use

Single lot covering all pharmaceutical products for compassionate and early access (ex-ATU). The DPS is not divided into product categories. Estimated annual value: €450 million (HT). Total estimated value over 10 years: €1.8 billion.

SuppliesDPSEU fundedElectronic submission

EUR 450M

Szacowana wartość

Czas trwania

Apr 2024 - Apr 2034

Kategoria

Pharmaceutical products

Termin

Deadline Apr 02, 2034

Szczegóły zamówienia

Data publikacji
01 Feb 2024
Języki
French

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
66960-2024

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3